Navigation Links
New Combination Locking Cap Designed to Protect Children and Teens From Prescription Medications
Date:9/26/2011

LINCOLN, Calif., Sept. 26, 2011 /PRNewswire/ -- Safely storing prescription medications has always been a challenge for parents and other prescription holders. Now, an innovative new device allows prescription holders to safely secure and store dangerous medications—in a small, convenient and more portable container.

(Photo: http://photos.prnewswire.com/prnh/20110926/SF75139)

Developed by CAP-N-LOCK, LLC., The Locking Cap is a combination locking cap designed to work with existing prescription medication bottles. The Locking Cap was designed to help families prevent unauthorized and undetected use of prescription medications for non-medical purposes. With a four-digit combination locking mechanism and sturdy PVC construction, it is easy to use, but virtually impossible to get past without detection.

"The Locking Cap eliminates unauthorized access to dangerous prescription drugs," said Joseph Simpson, President and product designer for CAP-N-LOCK. "The Locking Cap is very easy to operate. It protects families by blocking access to curious children and experimental teens. Plus, it features a compact design that allows for easy access and storage when traveling and at home."

The Locking Cap is designed and manufactured in the United States and is currently available in national pharmacies and online at http://www.TheLockingCap.com

About CAP-N-LOCK, LLC.

CAP-N-LOCK specializes in family safety product design, development, manufacturing and marketing. The non-medical use and abuse of prescription drugs is a serious and growing public health problem in the U.S. and is rapidly becoming a global epidemic. The majority of people use prescription medications responsibly; however, an estimated 48 million people in the U.S. (ages 12 and older) have used prescription drugs for non-medical reasons. The Locking Cap was created to protect families and help prevent prescription drug abuse and overdoses. For more information about The Locking Cap, visit http://www.TheLockingCap.com or call (408) 206-0120.  

Available at Ralphs, SaveMart, and Lucky Pharmacies.

Contact:
Deborah Simpson, Chairman & CEO, CAP-N-LOCK, LLC., at (408) 206-0120 or dsimpson@TheLockingCap.com


'/>"/>
SOURCE CAP-N-LOCK, LLC.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Pearl Therapeutics Bronchodilator Combination PT003 Provides Superior Inspiratory Capacity Compared to Spiriva®
2. SANYO Adds New MPR Series Biomedical Refrigerator/Freezer Combination Unit
3. Specialty Silicone Fabricators Adds Analytical Laboratory to Bolster Combination Product Services
4. Amylin and Takeda Discontinue Development of Pramlintide/Metreleptin Combination Treatment for Obesity Following Commercial Reassessment of the Program
5. Takeda Resubmits New Drug Applications in the U.S. for Investigational Type 2 Diabetes Therapies Alogliptin and the Fixed-Dose Combination Alogliptin/Pioglitazone
6. Tibotec Pharmaceuticals Announces Agreement With Gilead Sciences to Develop and Commercialize a New Fixed-Dose Combination of PREZISTA® and Cobicistat
7. Launch of Nuromol a New Painkiller Combination
8. ReportsnReports - Multitargeted Therapies: Promiscuous Drugs and Combination Therapies
9. Pearl Therapeutics Advances Its Long-Acting Bronchodilator Combination Product Candidate into Four Additional Phase 2 Studies
10. Argos Therapeutics Arcelis™ Immunotherapy for the Treatment of Renal Cell Carcinoma (RCC) in Combination With Sunitinib Demonstrates Strong Immunologic Response That Correlates to Improved Clinical Outcomes
11. All-Oral Combination Study with PSI-7977 for HCV Genotypes 1, 2 and 3 Initiated
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... HILLS, Calif. , June 23, 2016 Any ... the many challenges of the current process. Many of them ... because of the technical difficulties and high laboratory costs involved. ... have to offer it at such a high cost that ... afford it. Dr. Parsa Zadeh , founder ...
(Date:6/23/2016)... -- Roche (SIX: RO, ROG; OTCQX: RHHBY) announced that ... PCT (procalcitonin) assay as a dedicated testing solution for ... clearance, Roche is the first IVD company in the ... risk assessment and management. PCT is a ... in blood can aid clinicians in assessing the risk ...
(Date:6/23/2016)... June 23, 2016 Research and Markets ... Issue 52" report to their offering. ... treatment creates a favourable commercial environment for MedImmune to enter. ... base that will serve to drive considerable growth for effective ... serve to cap sales considerably, but development is still in ...
Breaking Medicine Technology:
(Date:6/25/2016)... ... June 25, 2016 , ... Experts from the ... AcademyHealth’s Annual Research Meeting June 26-28, 2016, at the Hynes Convention Center in ... topics including advance care planning, healthcare costs and patient and family engagement. , ...
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... The temporary closing of Bruton Memorial Library ... City Observer , brings up a new, often overlooked aspect of head lice: the parasite’s ... for fumigation is not a common occurrence, but a necessary one in the event that ...
(Date:6/25/2016)... ... June 25, 2016 , ... First Choice Emergency Room ... Dr. Sesan Ogunleye, as the Medical Director of its new Mesquite-Samuell Farm facility. ... of our new Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical Director of ...
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. ... from injury. Recently, he has implemented orthobiologic procedures as a method for treating ... one of the first doctors to perform the treatment. Orthobiologics are substances that ...
(Date:6/25/2016)... ... June 25, 2016 , ... Conventional wisdom preaches the ... In terms of the latter, setting the bar too high can result in disappointment, ... just slow progress toward their goal. , Research from PsychTests.com reveals ...
Breaking Medicine News(10 mins):